15th ICOC Conference


15th ICOC Conference (22 a 26 de abril de 2005)
15ª Conferência Internacional em Terapia Quelante Oral no Tratamento da
Talassemia e de Outras Doenças

- Site: www.icoc2005.org
- Local: China Medical University Hospital
No.2, Yude Rd., Taichung City 404, Taiwan

- Programação científica:

Main Theme
Chelation (drug) therapy in Thalassaemia

Major Topics
01. Oral iron chelators in the treatment of thalassemias and other
diseases.
02. Advances in the treatment of iron overload with L1- Deferiprone,
Deferoxamine and their combination.
03. The use of effective dose protocols in iron chelation therapy.
04. New iron chelators under development: Deferasirox (ICL670), Deferitrin
(GT-56 252), L1NAll.
05. Future strategies and developments in iron chelation.
06. Iron chelation in sickle cell anaemia, myelodysplasia, haemolytic
anaemia, renal dialysis, cancer and other diseases.
07. Iron metabolism and iron containing proteins in normal and disease
states.
08. Chemical, biochemical, pharmacological, toxicological, clinical and
therapeutic aspects of iron and other metals, chelating agents and drugs and
their complexes.
09. Conditions associated with metal imbalance, transfusions and chelating
drugs.
10. Monitoring of chelation therapy with invasive and non-invasive methods
(e.g. MRI, squid-biosusceptometry, "free" iron etc).
11. Heavy metals and radioactive metals-toxicity and metabolic aspects.
12. Diagnosis and prevention of the toxicity of chelating drugs and metal
inbalance.
13. Metal ions in health, disease and diagnostic medicine.
14. Biology, pharmacology and toxicology of metals and chelators.
15. Free radicals in biology and medicine: the role of antioxidants.
16. Recent advances in thalassaemia (all aspects).
17. Cancer chemotherapy and chelation.
18. Epidemiological aspects of chelation therapy in thalassaemia and other
diseases.
19. Psychological aspects of chelation and other drug therapies in
thalassaemia and other diseases.
20. Thalassaemia patient and parent session-expert panel question/answer
session.